Definition of relapse risk and role of nonanthracycline drags for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups

Blood

Volumn 96, Issue 4, 2000, Pages 1247-1253

  Sanz, M A ^a   Lo Coco, F ^a   Martin, G ^a   Avvisati, G ^a   Rayon, C ^a   Barbui, T ^a   Diaz Mediavilla, J ^a   Fioritoni, G ^a   Gonzalez, J D ^a   Liso, V ^a   Esteve, J ^a   Ferrara, F ^a   Bolufer, P ^a   Bernasconi, C ^a   Gonzalez, M ^a   Rodeghiero, F ^a   Colomer, D ^a   Petti, M C ^a   Ribera, J M ^a   Mandelli, F ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; ETOPOSIDE; IDARUBICIN; MITOXANTRONE; TIOGUANINE;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; DRUG EFFICACY; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; CYTARABINE; ETOPOSIDE; FEMALE; HUMANS; IDARUBICIN; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MITOXANTRONE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK; THIOGUANINE; TRETINOIN;

EID: 0034663162     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. All-trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: Long-term follow-up of the New York study
2. All-trans retinoic acid in acute promyelocytic leukemia
3. Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy
4. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
5. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Result of the randomized MRC trial
6. A randomized comparison of ATRA followed by chemotherapy and ATRA plus chemotherapy, and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia
7. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia
8. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia
9. The pathogenesis of acute promyelocytic leukemia: Evaluation of the role of molecular diagnosis and monitoring in the management of the disease
10. Molecular remission induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute premyelocytic leukemia
11. Early detection of relapse by prospective RT-PCR analysis of the PML/RARα fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter 'AIDA' trial
12. Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine
13. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the anti-PML monoclonal antibody PG-M3
14. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia
15. Nonparametric estimations from incomplete observations
16. Evaluation of survival data and two new rank order statistics arising in its consideration
17. A class of rank test procedures for censored survival data
18. Regression models and life tables (with discussion)
19. Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia
20. Long term follow-up confirms the superiority of ATRA combined with chemotherapy (CT) over CT alone in newly diagnosed acute promyelocytic leukemia